Physician profile
Derek Robert Freiheit
NPI 1649682097
$1,281.23
in general payments reported to CMS, 2019-2025
14 companies · $452 in 2025
The $452 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $36.96 · 2022: $186 · 2023: $403 · 2024: $203 · 2025: $452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,058.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,058.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $274.65 | 2023-2025 | |
| Kerecis Limited | $188.09 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Kci USA, INC. | $172.74 | 2021-2023 | Activ.A.C. |
| Urgo Medical North America, LLC | $172.35 | 2023-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgoclean Ag, Urgok2 |
| Mimedx Group, INC. | $144.40 | 2024-2025 | |
| Solventum Corporation | $90.90 | 2024-2025 | Activ.A.C., Promogran Prisma, 3m Coban |
| Tactile Systems Technology INC | $59.41 | 2022-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Smith+Nephew, INC. | $46.55 | 2023-2025 | Collagenase Santyl, Iodosorb Ointment 40g USA, Regranex |
| Tela Bio, INC. | $29.85 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Hollister Incorporated | $28.85 | 2022 | |
| Organogenesis INC. | $24.58 | 2024 | |
| Sanara Medtech INC. | $21.04 | 2023 | Celleraterx |
| Coloplast Corp | $14.86 | 2024 | |
| Integra Lifesciences Corporation | $12.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Freiheit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.